Experience

Davis Polk advised the sole placing agent for the primary placement of an aggregate of 78,000,000 new shares in Innovent Biologics, Inc. for a total consideration of approximately HK$2.4…

Davis Polk advised the joint book-running managers in connection with a $2.25 billion SEC-registered debt offering by Intel Corporation. The offering consisted of $750 million…

Davis Polk is advising an ad hoc group (the “Ad Hoc Group”) of prepetition secured term lenders and postpetition DIP term lenders in connection with American Commercial Lines Inc.’s …

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1.5 billion 1.500% guaranteed global…

Davis Polk advised the placement agent in connection with the approximately $13.5 million SEC-registered direct offering of 2,114,591 shares of common stock of Tellurian Inc. The shares are…

Davis Polk advised Afya Limited on its SEC-registered follow-on offering of an aggregate of 12,426,740 Class A common shares, of which 3,019,928 shares were issued and sold by Afya and…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 6,500,000 shares of common stock of Applied Genetic Technologies…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1.3 billion principal amount of its 0.300% notes due 2028, €1.6…

Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …

Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…